Special Populations in PHEs (III): Cancer

12th August 2020
16:00 - 17:00

Introduction

This webinar examines the impact of a PHE (i.e. COVID-19) on clinical research in oncology. It addresses the following questions: 

  1. What is the effect of COVID-19 on the epidemiology of cancer and current research & treatment programmes? 
  2. Are the responses to medicines and vaccine developments for COVID-19 useful for future clinical research in oncology? 
  3. How has clinical research in oncology been affected by the COVID-19 pandemic? 

Preparedness training webinar series

This webinar is part of our series on Preparedness Planning for Public Health Emergencies.

Find out more.

Meet the speakers

Moderator:
Dr Cecilia Chisholm MFPMMedical Trials Unit; Medicines and Health Products Regulatory Agency (MHRA)United Kingdom

Panellists:

  • Professor Igor Bondarenko, Head of Oncology and Medical Radiology Department, Dnipropetrovsk Medical Academy, Ukraine
  • Dr Mariam Hassan, Clinical Research Office at Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan
  • Dr Farah Rasheed, Clinical Research Office at Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan
  • Professor Richard Sullivan, Director, Institute of Cancer Policy, Co-Director Conflict & Health Research Group, Kings College London & NATO Biosecurity and Intelligence, United Kingdom
  • Elissa Prichep, Precision Medicine Lead, World Economic Forum, USA

This webinar is free to attend

  • IMPORTANT: If you are unable to complete your booking online, please email fpm@fpm.org.uk and we will book you onto the event.
  • This event is approved for CPD.

See our Terms & Conditions for booking and please note our privacy policy.

Joining instructions will be sent to attendees no earlier than Tuesday 11 August 2020.

 

If you have any queries, please email fpm@fpm.org.uk.

To find out about sponsorship opportunities for this series please email Will Strange at w.strange@fpm.org.uk